XBiotech XBIT Balance Sheet (2014-2026)

NASDAQ XBIT
$2.18 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

XBiotech Quarterly Balance Sheet

Periods 49 quarters
Latest Jun 2026

XBiotech reported total assets of $133.65M and total liabilities of $5.19M for the quarter ended Jun 2026, down 26.5% year over year. This balance sheet covers 49 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Accumulated Depreciation
19.98M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
315.30M238.90M236.98M231.82M225.80M160.60M157.31M152.50M143.40M202.20M200.02M201.04M188.53M183.12M172.68M155.90M152.94M147.40M125.55M109.53M
Receivables - NetNet Receivables
0.03M0.04M0.50M1.53M1.22M0.88M0.86M0.87M0.87M0.73M0.70M0.48M0.48M0.45M
Receivables - OtherOther Receivables
1.22M2.37M3.22M0.86M0.70M0.36M0.28M
Receivables
0.03M0.04M0.50M1.53M2.43M0.88M1.72M0.87M0.87M0.73M1.40M0.48M0.48M0.45M
Prepaid Assets
0.38M0.38M0.93M0.63M0.55M0.62M0.60M0.70M0.95M0.88M0.76M1.07M1.12M1.04M1.03M1.15M1.31M1.06M1.04M1.34M
Current Assets
324.86M250.24M246.87M242.98M238.76M223.43M219.84M216.28M209.51M204.40M201.72M203.06M190.64M185.03M174.57M157.69M154.89M148.95M126.95M111.16M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)
28.45M28.64M28.31M27.82M27.28M26.64M26.26M25.84M25.62M25.20M24.53M24.80M24.92M24.82M24.53M24.18M23.79M23.47M23.13M22.49M
Long-Term Deferred Tax
0.64M0.64M0.42M0.77M
Other Non-Current Assets
Non-Current Assets
29.09M29.28M28.31M27.82M27.70M27.41M26.26M25.84M25.62M25.20M24.90M24.80M24.92M24.82M24.53M24.18M23.79M23.47M23.13M22.49M
Assets
353.96M279.52M275.18M270.80M266.46M250.83M246.10M242.12M235.14M229.60M226.62M227.86M215.56M209.85M199.09M181.86M178.68M172.42M150.08M133.65M
Liabilities
Current Liabilities
Accounts Payables
1.49M1.01M2.07M1.32M2.45M1.38M2.41M1.36M1.82M1.47M2.52M2.61M1.70M1.51M2.22M1.10M1.43M1.04M1.53M1.10M
Payables
1.49M1.01M2.07M1.32M2.45M1.38M2.41M1.36M1.82M1.47M2.52M2.61M1.70M1.51M2.22M1.10M1.43M1.04M1.53M1.10M
Accumulated Expenses
1.68M1.64M1.37M1.57M5.59M1.99M1.60M2.21M2.63M3.67M3.50M4.19M5.35M4.49M2.63M4.30M2.41M2.42M6.32M2.25M
Other Accumulated Expenses
0.11M0.07M0.06M0.09M0.04M
Short term Debt
10.00M10.00M10.00M10.00M
Current Taxes
0.72M1.21M0.01M0.19M0.21M0.06M0.06M0.16M0.08M0.08M0.08M0.01M0.02M0.10M0.08M
Current Deferred Revenue
Total Current Liabilities
3.89M3.86M3.45M2.89M8.23M3.58M4.07M3.62M4.45M5.29M6.10M16.88M17.14M15.99M15.11M5.41M3.86M3.56M7.93M3.35M
Non-Current Liabilities
Non-Current Deffered Revenue
Non-Current Deferred Tax Liability
0.11M0.11M0.87M0.87M0.87M0.87M0.06M0.01M0.01M
Other Non-Current Liabilities
1.39M1.39M1.47M1.48M1.56M1.57M1.58M1.60M1.62M1.65M1.67M1.69M1.72M1.74M1.72M1.74M1.76M1.78M1.80M1.83M
Total Non-Current Liabilities
4.00M3.97M4.33M3.76M9.11M4.45M4.12M3.62M4.45M5.29M6.10M16.88M17.14M15.99M15.11M5.41M3.86M3.56M7.93M3.36M
Total Liabilities
5.39M5.36M5.79M5.24M10.67M6.03M5.70M5.22M6.07M6.94M7.77M18.58M18.85M17.74M16.82M7.15M5.62M5.34M9.73M5.19M
Shareholder's Equity
Total Debt
10.00M10.00M10.00M10.00M
Common Equity
348.56M274.16M269.38M265.56M255.79M244.81M240.40M236.91M229.06M222.66M218.85M209.28M196.70M192.12M182.27M174.71M173.06M167.08M140.35M128.46M
Liabilities and Shareholders Equity
353.96M279.52M275.18M270.80M266.46M250.83M246.10M242.12M235.14M229.60M226.62M227.86M215.56M209.85M199.09M181.86M178.68M172.42M150.08M133.65M
Retained Earnings
89.88M11.62M5.15M2.09M-11.89M-24.55M-27.75M-31.57M-40.31M-47.67M-52.31M-62.31M-75.31M-80.33M-90.84M-101.72M-103.48M-109.48M-136.38M-148.61M